In celebration of International Cochlear Implant Day, Cochlear North America is proud to announce the recipients of the 2026 Cochlear Academic Scholarships. This year, eight exceptional students, who ...

Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, ...

Unlike hearing aids, cochlear implants require regular rehabilitation and updates throughout your life. Share on Pinterest Stocksy/Erin Brant Some people in the Deaf community may opt to receive ...

Cochlear implant surgery helps people with severe hearing loss by placing an electronic device inside the inner ear. To reach the inner ear, surgeons must first remove part of a bone behind the ear, ...

Upgradeable Firmware: The Cochlear™ Nucleus ® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.

Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. Late last month, cochlear implant maker Cochlear announced a coalition ...

BackgroundCochlear implants (CIs) are among the most successful neuroprosthetic technologies, restoring access to sound for individuals with ...

A medical device that has allowed thousands of deaf individuals worldwide the opportunity to hear—sometimes for the first time and well enough to talk on the telephone—is the focus of 15 personal ...

Australian company Cochlear has teamed up with Apple to release the world’s first cochlear implant sound processor made for iPhone. The Nucleus 7 sound processor will allow users to stream sounds ...

Cochlear implants support hearing in profoundly deaf people ‘Balance of power’ between brain areas may affect how effective implants are Goal is to find ways to help kids better adapt to implants Four ...

On March 4, the first-ever National Forum on Cochlear Implantation – 2026 will take place in the republic at the Nizami ...

The average one-year price target for Cochlear (ASX:COH) has been revised to $265.71 / share. This is a decrease of 15.30% from the prior estimate of $313.70 dated February 1, 2026. The price target ...